During a live endoscopy course ((b)(6) live), prof.(b)(6) was placing an evo-fc-r-e in a pt.This first stent was not successfully placed.Reference mdr report # 3001845648-2014-00224 for details.Prof.(b)(6), repeated the procedure with a new evo-fc-r-e.After deployment of the new stent and prior to removal of the system he viewed the stent under endoscopic visualization.He noted the sutures in the newly placed stent were preventing the stent from opening.He negotiated the introducer out of the stent and then finished the procedure by expanding the stent that remained in the patient using the hercules dilation balloon.No adverse effects to the patient have been reported as occurring as a result of this incident.
|
This device is not registered for sale in the united states.However, indication for use has been confirmed as malignant.Therefore this device is considered 'similar' to other metal stent/sets (evolution) devices currently marketed in the united states based on this malignant indication.Note confirmation of this malignant indication was received on 10/14/2014; initial complaint details received had reported the indication for use as benign.Similar metal stent/sets (evolution) are currently marketed in the united states under the following 510(k) #: k093619, k080359, k101530, k113510, k121430.Fda mdr reporting required based on the action of the physician to dilate the unexpanded stent.A reporting precedence also exists for this product family for the stent not expanding.The device was not available to be returned as it was implanted in the pt.With the info provided a document based investigation was carried out.A possible cause of the stent not releasing could be if the stent crown had become caught between the bi lumen and pert collar.However, as the device was not available for evaluation we cannot conclusively determine the cause of this complaint.The customer complaint could be confirmed based on customer testimony.Prior to distribution all evo-fc-r-20-25-12-e devices are subjected to functional checks and visual inspection to ensure integrity of the product.As per relevant production instruction, there is a specific check to deploy the stent approx 50% and recapture it to ensure it functions correctly.As per instructions for use, it states: "if package is opened or damaged when received, do not use.Visually inspect with particular attention to kinks, bends and breaks.If an abnormality is detected that would prohibit proper working condition, do not use." there were no adverse affects to the pt reported as a result of this occurrence.Complaints of this nature will continue to be monitored for potential emerging trends.
|